Merck`s 21-valent pneumococcal jab gears up for Prevnar 20 rivalry
29 Nov 2023 //
BUSINESSWIRE
EC Expands Merck’s VAXNEUVANCE Indication to Include Infants and Adolescents
24 Oct 2022 //
BUSINESSWIRE
Media report claiming shortage of pneumococcal vaccines `ill-informed`
08 Oct 2022 //
ECONOMIC TIMES
Pfizer racks up EU infant win for 20-valent pneumococcal vaccine
20 Sep 2022 //
FIERCEBIOTECH
US clears Merck & Co.`s Vaxneuvance 15-valent pneumococcal vaccine
19 Jul 2021 //
PRESS RELEASE